Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.
- NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_assertion wasGeneratedBy ECO_0000203 NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.
- NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_assertion wasDerivedFrom befree-20140225 NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.
- NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_assertion SIO_000772 22236010 NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.
- NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_assertion evidence source_evidence_literature NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.
- NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_assertion description "[This study was conducted to document the proportion of CD4(+) /interleukin (IL)-17A(+) -, CD16(+) /indoleamine 2, 3-dioxygenase (IDO(+) )-, forkhead box protein P3 (FoxP3(+))-expressing cells, senescent cells (p16(INK) (4α)) and the percentage of interstitial fibrosis (IF) in graft biopsies of kidney transplant recipients participating in the BENEFIT (Bristol-Myers Squibb IM103008) study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP507115.RApdmADNgos7yFejj5p4H3vDq2qZQEbGJGn3wh4PSQlsg130_provenance.